Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial (Q46839548)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial |
scientific article |
Statements
1 reference
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial (English)
1 reference
1 reference
B P Coudert
1 reference
L Arnould
1 reference
L Moreau
1 reference
P Chollet
1 reference
B Weber
1 reference
L Vanlemmens
1 reference
C Moluçon
1 reference
S Causeret
1 reference
J-L Misset
1 reference
S Feutray
1 reference
D Mery-Mignard
1 reference
J Garnier
1 reference
P Fumoleau
1 reference
6 December 2005
1 reference
1 reference
17
1 reference
3
1 reference
409-414
1 reference
Identifiers
1 reference
1 reference